Literature DB >> 7298160

Neutrophil responses to platelet-activating factor.

J T O'Flaherty, C H Miller, J C Lewis, R L Wykle, D A Bass, C E McCall, M Waite, L R DeChatelet.   

Abstract

1-O-Alkyl-2-O-acetyl-sn-glycerol-3-phosphorylcholine (i.e., platelet-activating factor) was prepared and confirmed to possess potent platelet aggregating activity. It was also potent in aggregating and degranulating rabbit and human neutrophils. When injected into rabbits, the lipid induced profound neutropenia, thrombocytopenia, and anaphylactic symptoms. The lyso derivative of this lipid, 1-O-alkyl-sn-glycerol-3-phosphorylcholine, was inactive or several orders of magnitude weaker in inducing these responses. The acetylated lipid appears to be a potent stimulator of both platelets and neutrophils. Its anaphylactic-like toxicity may be related, at least in part, to its ability to aggregate or otherwise stimulate these cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298160     DOI: 10.1007/bf00914443

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

1.  Neutrophil aggregation and swelling induced by chemotactic agents.

Authors:  J T O'Flaherty; D L Kreutzer; P A Ward
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  The effects of extracellular K+, Na+ and Ca++ on lysosomal enzyme secretion from polymorphonuclear leukocytes.

Authors:  H J Showell; P H Naccache; R I Sha'afi; E L Becker
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Isolation of a chemical trigger for thrombosis.

Authors:  A L Willis
Journal:  Prostaglandins       Date:  1974-01-10

4.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

5.  Effect of intravascular complement activation on granulocyte adhesiveness and distribution.

Authors:  J T O'Flaherty; P R Craddock; H S Jacob
Journal:  Blood       Date:  1978-04       Impact factor: 22.113

6.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Authors:  L M McManus; D J Hanahan; C A Demopoulos; R N Pinckard
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents.

Authors:  E J Goetzl; C K Derian; A I Tauber; F H Valone
Journal:  Biochem Biophys Res Commun       Date:  1980-06-16       Impact factor: 3.575

8.  Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung.

Authors:  J T O'Flaherty; S Cousart; A S Lineberger; E Bond; D A Bass; L R DeChatelet; E S Leake; C E McCall
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

9.  Arachidonic acid causes sudden death in rabbits.

Authors:  M J Silver; W Hoch; J J Kocsis; C M Ingerman; J B Smith
Journal:  Science       Date:  1974-03-15       Impact factor: 47.728

10.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  8 in total

1.  Platelet-derived growth factor stimulates phagocytosis and blocks agonist-induced activation of the neutrophil oxidative burst: a possible cellular mechanism to protect against oxygen radical damage.

Authors:  E Wilson; S M Laster; L R Gooding; J D Lambeth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

2.  Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.

Authors:  N P Stimler; J T O'Flaherty
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

Review 3.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

4.  Pulmonary injury induced by phorbol myristate acetate following intravenous administration in rabbits. Acute respiratory distress followed by pulmonary interstitial pneumonitis and pulmonary fibrosis.

Authors:  C E McCall; R G Taylor; S L Cousart; R D Woodruff; J C Lewis; J T O'Flaherty
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

5.  Binding and metabolism of platelet-activating factor by human neutrophils.

Authors:  J T O'Flaherty; J R Surles; J Redman; D Jacobson; C Piantadosi; R L Wykle
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.

Authors:  M Watanabe; M Yamada; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

7.  Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.

Authors:  J G Filep; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

8.  Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.

Authors:  S E Goldblum; W P Reed
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.